| pubmed-article:8422646 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C1704247 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0442034 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0542341 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C0486616 | lld:lifeskim |
| pubmed-article:8422646 | lifeskim:mentions | umls-concept:C1511636 | lld:lifeskim |
| pubmed-article:8422646 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8422646 | pubmed:dateCreated | 1993-2-22 | lld:pubmed |
| pubmed-article:8422646 | pubmed:abstractText | In patients with epithelial ovarian cancer (EOC), the cellular composition in the peritoneal cavity and the functional capacities of the peritoneal cells (PC) are unknown. Especially the peritoneal macrophages (m phi) could play an important role in defense against tumor cells. To study the cellular composition in the peritoneal cavity and the functional capacities of PC, these cells were obtained from three patients with EOC. The PC were immunophenotyped and tested functionally in vitro in a cytotoxicity assay. One of the patients was treated intraperitoneally (i.p.) with a single dose of 0.06 mg/m2 tumor necrosis factor-alpha (TNF-alpha). PC were obtained before the treatment, after 24 h and after 1 week. PC from healthy women undergoing laparoscopic sterilization served as controls. It appeared that patients with EOC have a lower percentage of macrophages (m phi) in the peritoneal cavity than healthy persons. These m phi of patients were also less capable of killing U 937 tumor cells as compared to the peritoneal m phi of control persons. However, in the patient treated i.p. with TNF-alpha the cytotoxic capacities of the peritoneal m phi were strongly improved. The percentage cytotoxicity at an effector to target ratio of 10, increased from 17% to 80%. Thus, the peritoneal m phi in this patient were activated in vivo to a tumoricidal state. These findings indicate that PC in patients with EOC differ from controls, but further investigation is necessary to define the contribution of the disease and/or prior chemotherapy to this defect. | lld:pubmed |
| pubmed-article:8422646 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8422646 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8422646 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8422646 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8422646 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8422646 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:8422646 | pubmed:issn | 0304-3835 | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:BlekerO POP | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:BeelenR HRH | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:VermorkenJ... | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:KenemansPP | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:CalameWW | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:BurgerC WCW | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:van de... | lld:pubmed |
| pubmed-article:8422646 | pubmed:author | pubmed-author:RichtersC DCD | lld:pubmed |
| pubmed-article:8422646 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8422646 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:8422646 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:8422646 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8422646 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8422646 | pubmed:pagination | 25-31 | lld:pubmed |
| pubmed-article:8422646 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:meshHeading | pubmed-meshheading:8422646-... | lld:pubmed |
| pubmed-article:8422646 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8422646 | pubmed:articleTitle | The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-alpha treatment. | lld:pubmed |
| pubmed-article:8422646 | pubmed:affiliation | Department of Obstetrics and Gynaecology, Free University Hospital, Amsterdam, The Netherlands. | lld:pubmed |
| pubmed-article:8422646 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8422646 | pubmed:publicationType | Case Reports | lld:pubmed |
